CTRI/2009/091/000435OtherPhase 1
A Pilot study on the use of Allogeneic Mesenchymal stem cells for Osteoarthritis
Trial Snapshot
- Phase
- Phase 1
- Status
- Other
- Sponsor
- Stempeutics Research Pvt Ltd
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1) History of primary idiopathic osteoarthritis of the knee characterized by pain of moderate intensity which requires intake of analgesics at least 3 days a week. 2) Self-reported difficulty in at least one of the following activities attributed to knee pain: lifting and carrying groceries, walking 400 metres, getting in and out of a chair, or going up and down stairs. 3)Radiographic evidence of grade 1 to 3 osteoarthritis based on the Kellgren and Lawrence radiographic entry criteria.4) Patients who have been on stable medication for the past three months.5) Able to complete a 1-week washout period during which NSAIDs are prohibited. 6) Patients who have not received intraarticular steroids or hyaluronan within the last three months. 7) Ability to provide written informed consent.
Exclusion Criteria
- •1) Prior or ongoing medical conditions (e.g., concomitant illness, psychiatric condition, alcoholism, drug abuse), medical history, physical findings, ECG findings, or laboratory abnormality that, in the investigator?s opinion, could adversely affect the safety of the subject, makes it unlikely that the course of treatment or follow-up would be completed, or could impair the assessment of study results. 2) History of surgery, including arthroscopy, or major trauma to the study joint in the previous 12 months 3) Signs of active study joint inflammation including redness, warmth, and/or, if qualifying with osteoarthritis of the knee, a large, bulging effusion of the study knee joint with the loss of normal contour of the joint at the screening visit or at the baseline examination after the washout period 4) Infections in or around the knee. 5) Patients awaiting a replacement knee or hip joint 6) Patients with other conditions that cause pain 7) Patients taking corticosteroid medication or Hyaluronan injection within last 3 months. 8) Significantly incapacitated or disabled and would be categorized as ACR Functional Class IV (largely or wholly incapacitated), or unable to walk without assistive devices 9) Patients with other known rheumatic or inflammatory disease such as rheumatoid arthritis 10) Other pathologic lesions on x-rays of knee 11) Positive hepatitis B surface antigen, hepatitis C antibody test, Anti human immunodeficiency virus (HIV) antibody test, or VDRL. 12) Bleeding disorders. 13) Known hypersensitivity to Hyaluronan products or animal sera. 14) For women of child-bearing potential: positive pregnancy test or lactating
Investigators
Similar Trials
Unknown
Phase 1
Allogenic mesenchymal stem cells in patients with Dilated CardiomyopathyCTRI/2009/091/000437Stempeutics Research Pvt Ltd20
Unknown
Phase 1
A study with allogenic mesenchymal stem cells in patients with Chronic Obstructive Pulmonary Disease (COPD)CTRI/2009/091/000436Stempeutics Research Pvt Ltd30
Unknown
Phase 1
A controlled study with allogenic mesenchymal stem cells in patients with Liver CirrhosisCTRI/2009/091/000432Stempeutics Research Pvt Ltd
Recruiting
Not Applicable
An open label, non randomized, uncontrolled, bio interventional, single centric, pilot study in Traumatic Brain InjuryCTRI/2010/091/000436ADVANCED NEURO-SCIENCE ALLIES PVT. LTD#560, Bhargavi, 9th "A" Main, Indiranagar, Bangalore-560 038Karnataka (INDIA)15
Recruiting
Not Applicable
"A Pilot Study on the use of Allogenic Mesenchymal Stem cells for Osteoarthritis"CTRI/2010/091/000270ADVANCED NEUROSCIENCE ALLIES PRIVATE LIMITED40